The market of ciclopirox is known to treat fungal infections and is thus forecasted to see steady growth. The global ciclopirox market creates a value of US$ 11.8 million by the end of 2023 and is expected to grow at a CAGR of 5.2% in order to touch it at US$ 19.5 million by 2033. Market size-relative and expected expansion across various regions-is one of the key insights about the market. The increasing disposable income, growing e-commerce penetration, and a rise in awareness of personal hygiene drive market growth.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8872

The major drawback to the global expansion of the ciclopirox market is the high cost of the products compared to other alternative agents for antifungals. The regulatory hurdles and need for approvals further slowdown the expansion​.

Key Companies Profiled

• Kumar Organic Products Limited
• Pharmaffiliates
• Seqens Group
• Fengchen Group Co. Ltd
• MuseChem Chemicals
• B JOSHI AGROCHEM PHARMA

What is Ciclopirox Anhydrous used for?

Ciclopirox belongs to a class of drugs used in antifungal therapy for various types of fungus infection. Common uses include the treatment of athlete's foot, ringworm, nail fungus infection, and seborrheic dermatitis. Mode of action: It inhibits the growth of fungi on your skin or nails towards its end, making it great for preventing and curing superfine mycoses. This drug is used in cream, lotion, and lacquer forms.

Most ciclopirox-based products are classified according to their level of purity. More potent, over 98% pure ciclopirox is used in combating severe infections like onychomycosis, effectively eradicating fungi and any further growth. Less pure formulations are typically targeted for treating yeast and must infections that can easily be controlled and are less frequently used because of their reduced effectiveness.

The growth rates of the Ciclopirox product market have been quite rapid in china, and a few factors account for this. It majorly deals with the aging population because the demand for antifungal treatments in the country is increasing. In 2020, approximately 18% of the population in China were above 60 years, and this is set to increase, which increases fungal infections because many of the conditions develop in old age. Moreover, with rising e-commerce in China, consumers easily gain access to the ciclopirox products thus boosting various company sales.

United States

In the U.S. the ciclopirox markets have been on the rise courtesy of some of the environmental and lifestyle factors rampant. The recent high temperatures, which are brought about by global warming, have majorly helped in the increased infections of fungi. These temperatures catalyze fungal growth since the humidity and heat increase remarkably boosting the fungi growth rate. In addition, skin diseases and burn injuries, which may result in fungal infection, increased the demand for ciclopirox-based treatments. Also, in the U.S., increasing awareness of personal hygiene is driving the increased use of antifungal products​.

Other Key Markets

Apart from China and the U.S., other emerging markets include Europe, Latin America, and Southeast Asia, where the demand for ciclopirox maintains a healthy growth pattern. Increased incidence of fungal infections, improvement in healthcare infrastructure, and extension of distribution networks in these regions are factors that drive market development. Creams remain the most preferred products in these regions due to ease of application and easy accessibility in all major pharmacies​.

Product Insights

Creams are the largest single category of product in most antifungal markets. Creams are popular because they are convenient, inexpensive, and generally safe. Further, creams are also less invasive when compared with topical solutions that have a higher concentration of medication, as well as oral medications. The reason this is true is that a ciclopirox cream used for the treatment of fungal infections on the skin is much less likely to cause adverse reactions; therefore, these treatments may be purchased OTC and are marketed more widely across most retail and internet ​platforms.

Apart from creams, ciclopirox also comes in other available forms such as gels, lotions, and nail lacquers. More of these may also offer solutions in case of some different kinds of infections or a more potent solution in case of hard-to-treat conditions, such as nail fungi, for which standard topical treatment is relatively less effective. Discussed below are some of the factors that contribute to the high market demand for such products.

Challenges and Opportunities

Although the ciclopirox market is witnessing an upward growth trajectory with prospects, certain factors may hinder the size of the market. The major challenges are the high price of ciclopirox products versus other antifungal treatments, which makes these products sullenly unaffordable in price-sensitive regions. Long and tedious regulatory approval for ciclopirox products is also one of the challenges that may be faced by manufacturers in bringing new formulations into the market within a short time. The competition from other antifungal agents is a restraint to the market growth since there are so many options available for the patients and healthcare providers at their discretion​.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=8872

There are opportunities in the market for the players to create innovations and product differentiation. The more cost-effective versions of ciclopirox and further exploitation of online channels for sales would increase the market penetration. Other ways of targeting growth could be poor countries that have high rates of fungal infection and other regions with an aging population.

The ciclopirox market is expected to grow along with an increase in the general demand for antifungal therapies and facilitated e-commerce. Some of the main markets that are growing at a very good pace include China and the U.S., because of the change in demographics and rising awareness toward hygiene. Thus, there are always some continuous challenges in the form of cost barriers, regular competition, and alternate antifungal agents. On the contrary, the manufacturing companies may have to look at product differentiation and affordability along with expanding their networks of distribution to cash in on the emerging opportunities.

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com